# FDA Inspection 1002396 - Novel Laboratories, Inc. d.b.a Lupin Somerset - February 14, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/e9816101-4ee4-4250-b106-e635c77e2b68/
Source feed: FDA_Inspections

> FDA Inspection 1002396 for Novel Laboratories, Inc. d.b.a Lupin Somerset on February 14, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002396
- Company Name: Novel Laboratories, Inc. d.b.a Lupin Somerset
- Inspection Date: 2017-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1285934 - 2025-10-10](https://www.globalkeysolutions.net/api/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/dfddb031-7d66-4dc1-82ad-c66090b0c800/)
- [FDA Inspection 1259938 - 2025-01-31](https://www.globalkeysolutions.net/api/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/79f379b8-551a-4c4d-b825-72508514c6fd/)
- [FDA Inspection 1235495 - 2024-05-17](https://www.globalkeysolutions.net/api/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/47eb9329-2372-4457-9525-d2df8c6bc801/)
- [FDA Inspection 1197049 - 2023-01-13](https://www.globalkeysolutions.net/api/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/c29bdd8e-f68a-4554-b27f-a094c6c578d0/)
- [FDA Inspection 1168160 - 2022-03-30](https://www.globalkeysolutions.net/api/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/5a65ed50-592e-4c81-9120-8d691193d983/)

Company: https://www.globalkeysolutions.net/companies/novel-laboratories-inc-dba-lupin-somerset/53a42119-c077-49fb-b739-db29c2b99391

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c